Migraine– Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2021 To 2032
Migraine is a type of headache that
causes severe throbbing or pulsing pain on one side of the head. It's often
accompanied by nausea, vomiting, and extreme light and sound sensitivity.
Migraine attacks can last anywhere from hours to days, and the pain can be
severe enough to prevent you from going about your daily activities. It is
likely to be a brain disorder involving altered regulation and control of
afferents, with a particular focus on the cranium. Migraine is a sensory
processing disturbance with broad ramifications for central nervous system
function. While pain is used as the exemplar symptom, a brain-centered
explanation provides a framework for understanding all the manifestations of
migraine. For some people, a warning symptom known as an aura occurs before or
with the headache. An aura can include visual disturbances, such as flashes of
light or blind spots, or other disorders, such as tingling on one side of the
face or in an arm or leg and difficulty speaking. Migraines, affecting
children, teenagers, and adults, can progress through four stages: prodrome,
aura, attack, and post-drome. Not everyone who has migraines goes through all
stages.
- The prevalence and burden of
self-reported migraine and severe headaches in the US adult population is
high, affecting roughly 1 out of every 6 American and 1 in 5 women, 9.7%
of males and 20.7% of females are being diagnosed.
Thelansis’s “Migraine Market Outlook,
Epidemiology, Competitive
Landscape, and Market Forecast Report – 2021 To 2032" covers disease
overview, epidemiology, drug utilization, prescription share analysis,
competitive landscape, clinical practice, regulatory landscape, patient share,
market uptake, market forecast, and key market insights under the potential Migraine
treatment modalities options for eight major markets (USA, Germany, France,
Italy, Spain, UK, Japan, and China).
KOLs insights
of Migraine across 8 MM market from the centre of Excellence/ Public/ Private
hospitals participated in the study. Insights around current treatment
landscape, epidemiology, clinical characteristics, future treatment paradigm,
and Unmet needs.
Migraine Market Forecast Patient
Based Forecast Model (MS. Excel Based Automated Dashboard), which Data Inputs
with sourcing, Market Event, and Product Event, Country specific Forecast
Model, Market uptake and patient share uptake, Attribute Analysis, Analog
Analysis, Disease burden, and pricing scenario, Summary, and Insights.
Thelansis Competitive Intelligence (CI) practice
has been established based on a deep understanding of the pharma/biotech
business environment to provide an optimized support system to all levels of
the decision-making process. It enables business leaders in forward-thinking
and proactive decision-making. Thelansis supports scientific and commercial
teams in seamless CI support by creating an AI/ ML-based technology-driven
platform that manages the data flow from primary and secondary sources.
Comments
Post a Comment